【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 14
2 Introduction 15
2.1 Cardiac Rhythm Management Devices Overview 15
3 Products under Development 17
3.1 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 17
3.2 Cardiac Rhythm Management Devices – Pipeline Products by Segment 18
3.3 Cardiac Rhythm Management Devices – Pipeline Products by Territory 20
3.4 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 21
3.5 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 22
3.6 Cardiac Rhythm Management Devices – Ongoing Clinical Trials 24
4 Cardiac Rhythm Management Devices – Pipeline Products under Development by Companies 25
4.1 Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 25
4.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 27
5 Cardiac Rhythm Management Devices Companies and Product Overview 31
5.1 AI Medical Semiconductor Ltd. Company Overview 31
5.1.1 AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AIS Inc. Company Overview 33
5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.3 Biotronik SE & Co. KG Company Overview 34
5.3.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Scientific Corporation Company Overview 45
5.4.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
5.5 Boston TransTec, LLC Company Overview 76
5.5.1 Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview 76
5.6 CardiaLen, Inc. Company Overview 78
5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.7 CVRx, Inc. Company Overview 80
5.7.1 CVRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.8 DHS Medical Company Overview 84
5.8.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 84
5.9 Duke University Company Overview 86
5.9.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 86
5.10 EBR Systems, Inc. Company Overview 88
5.10.1 EBR Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.11 Endurance Rhythm Inc. Company Overview 92
5.11.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.12 Greatbatch, Inc. Company Overview 93
5.12.1 Greatbatch, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.13 Hadasit Medical Research Services & Development Ltd Company Overview 95
5.13.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
5.14 Impulse Dynamics N.V. Company Overview 97
5.14.1 Impulse Dynamics N.V. Pipeline Products & Ongoing Clinical Trials Overview 97
5.15 Imricor Medical Systems, Inc. Company Overview 102
5.15.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.16 InnerPulse, Inc. Company Overview 103
5.16.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.17 Kenergy Inc. Company Overview 105
5.17.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.18 Krisara Engineering, LLC Company Overview 107
5.18.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 107
5.19 LifeWave Hi-Tech Medical Devices Ltd. Company Overview 108
5.19.1 LifeWave Hi-Tech Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 108
5.20 Mathematical Bio-Solutions Inc. Company Overview 110
5.20.1 Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.21 Mayo Clinic. Company Overview 111
5.21.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 111
5.22 Medtronic plc Company Overview 115
5.22.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 115
5.23 MicroPort Scientific Corporation Company Overview 126
5.23.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 126
5.24 MRI Interventions, Inc Company Overview 130
5.24.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 130
5.25 NanoLinea Company Overview 132
5.25.1 NanoLinea Pipeline Products & Ongoing Clinical Trials Overview 132
5.26 NDSU Research Foundation Company Overview 133
5.26.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 133
5.27 NuVascular Technologies Inc Company Overview 134
5.27.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 134
5.28 Odem Medical Ltd. Company Overview 135
5.28.1 Odem Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.29 Perpetuum Ltd. Company Overview 138
5.29.1 Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 138
5.30 Queen Mary University of London Company Overview 139
5.30.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 139
5.31 Rochester Institute of Technology Company Overview 140
5.31.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 140
5.32 Semprus BioSciences Company Overview 141
5.32.1 Semprus BioSciences Pipeline Products & Ongoing Clinical Trials Overview 141
5.33 Smartwave Medical Ltd Company Overview 142
5.33.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 142
5.34 Sorin Group Italia S.r.l Company Overview 143
5.34.1 Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview 143
5.35 Sorin S.p.A. (Inactive) Company Overview 148
5.35.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 148
5.36 St. Jude Medical, Inc. Company Overview 174
5.36.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 174
5.37 The Johns Hopkins University Company Overview 189
5.37.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 189
5.38 The University of Utah Company Overview 197
5.38.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 197
5.39 TransWorld Med Corporation Company Overview 198
5.39.1 TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview 198
5.40 U.S. Stem Cell, Inc. Company Overview 201
5.40.1 U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
5.41 University of Bern Company Overview 203
5.41.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 203
5.42 University of California, Los Angeles Company Overview 204
5.42.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 204
5.43 University of Leicester Company Overview 205
5.43.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 205
5.44 University of Michigan Company Overview 206
5.44.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 206
6 Cardiac Rhythm Management Devices- Recent Developments 208
7 Appendix 390
7.1 Methodology 390
7.2 About GlobalData 392
7.3 Contact Us 393
7.4 Disclaimer 393
【レポート販売概要】
■ タイトル：世界の心調律管理装置開発動向：医療機器パイプライン分析2015■ 英文：Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0130EPD
■ 調査対象地域：グローバル
- 血管形成術用バルーンの世界市場分析：タイプ別（通常のバルーン、薬物溶出バルーン、切断バルーン、スコアリングバルーン）、用途別（末梢、冠動脈）、エンドユーザー別、地域別、セグメント予測 2013 – 2024The global angioplasty balloon market is expected to reach a value of USD 2.9 billion by 2024, according on a new report by Grand View Research, Inc. The growth of the market is attributed to favorable government policies, approval & commercialization of several angioplasty balloons, and increasing coronary & peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients a …
- エアブレーキシステムの世界市場予測（～2025年）“Increasing sales and production of commercial & OHV trucks, increasing railways & high-speed trains will drive the air brake system market.”The air brake system market is estimated to be USD 4.5 billion in 2018 and is projected to reach USD 5.6 billion by 2025, at a CAGR of 3.31% during the forecast period. The demand for the air brake systems is driven by the increasing sales and production of c …
- 医療用センサーの世界市場2019-2023About this market The rising demand for medical sensors in home care settings will trigger the growth of the market in the forthcoming years. The demand for medical sensors is further boosted by the increasing adoption of medical sensors among end-users such as home care settings. In addition, due to the rise in medical treatments in hospitals and clinics, patients are shifting from treatment in h …
- スマートセキュリティ製品の世界市場：監視、アクセス制御、侵入防止システム、侵入者警報、ソフトウェアAbout Smart Security Smart security solutions are used to monitor the activities and behavior of people in areas that are more prone to unauthorized access or damage, such as enterprises, educational institutions, commercial buildings, and utility infrastructure. Smart security includes advanced security systems such as IP surveillance cameras, biometric access control systems, integrated perimete …
- Gantenerumab (Alzheimer’s Disease)：市場予測と分析（～2022）Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic ther …
- 医療機器業界のM&A及び投資動向（四半期別）：Q3 2013Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q3 2013 Summary GlobalData’s “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q3 2013” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private eq …
- 研究開発アウトソーシングのグローバル市場動向（2014-2018）About Global R&D Outsourcing Market R&D Outsourcing refers to the outsourcing of specific R&D services to third-party service providers such as designing, prototyping, testing, and manufacturing and sales. Though R&D services are a critical part of any vertical, the recent economic downturn and the need to survive in extremely competitive market environments has forced organizations to outsource t …
- 個人用冷却装置の世界市場：エアコン/卓上扇風機、携帯型冷却装置The personal cooling device market is expected to reach USD 6.9 Million by 2022, at a CAGR of 5.3% during the forecast period. The major drivers for the personal cooling device market are energy efficiency, individual comfort offering, and portable & user friendly personal cooling devices. Personal cooling devices are energy efficient and less expensive which provide comfort to individuals without …
- 創傷被覆材の世界市場：先進創傷被覆材、従来型創傷被覆材The global wound dressings market is estimated to be valued at USD 6.31 Billion in 2016, and is projected to grow at a CAGR of 6.0% from 2016 to 2021, to reach USD 8.46 Billion by 2021. Advanced wound dressings segment registered the largest market share in 2015 and is expected to grow at a CAGR of 6.9%. Increasing awareness regarding wound care management, high growth potential of emerging econom …
- Unit Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- フルオロケイ酸の世界市場2019-2023Global Fluorosilicic Acid Market: About this market Technavio’s fluorosilicic acid market analysis considers sales from water fluoridation, chemical manufacturing, metal surface treatment, and electroplating, hide processing, and others. Our analysis also considers the sales of fluorosilicic acid in APAC, Europe, North America, South America, and MEA. In 2018, the water fluoridation segment had a …
- Xバンドレーダーの世界市場予測（～2021年）：モバイルXバンドレーダー、海上配備XバンドレーダーThe global X-band radar market is projected to grow from USD 4.58 Billion in 2016 to USD 5.61 Billion by 2021, at a CAGR of 4.1% during the forecast period. Factors such as increasing crime in the form of territorial conflicts, emergence of electronic and network centric warfare, replacement of legacy systems resulting in the automaton of radar systems, and increasing use of the X-band radar in de …
- ふっ素化エチレンプロピレン（FEP）塗料の世界市場The Global FEP coating market report defines and segments the concerned market with analysis and forecast of revenue. This market was valued at $114.9 million in 2014 and is expected to reach a value of $199.3 million by 2019 at a CAGR of 7.0% from 2014 and 2019. In 2014, the Asia-Pacific region dominated the global market for FEP coating with the largest market share of 36.9% and it is expected t …
- 虫垂炎(Appendicitis)：世界の治験レビュー（2015年上半期版）Appendicitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, H1, 2015" provides data on the Appendicitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Appendicitis. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 世界の射出成形機市場2015The Global Injection Molding Machine Industry Report 2015 is a professional and in-depth study on the current state of the Injection Molding Machine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Injection Molding Machine market analysis is provided for the international markets including develop …
